Delivery Order SPE2DR25D2010-SPE2DR26F4ZPF
- Not listed
- The Defense Logistics Agency awarded a $85,522.33 delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $71,223.81 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of December 9, 2025. The award was made without a set-aside designation, reflecting open competition among qualified vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,346.58 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets in 30-unit packages. The contract is a non-set-aside, firm fixed price delivery order with an ultimate completion date of August 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for $11,316.77 to supply Triumeq 600-50-300 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open competition process. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of January 7, 2026. AmerisourceBergen Drug Corp is a...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TRIUMEQ 600-50-300 MG tablets (30-count units) with a ceiling value of $78,899.37. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $6,519.84 for TRIUMEQ 600-50-300 mg tablets in quantities of 30, with a firm fixed price contract type. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $7,217.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of TRIUMEQ 600-50-300 mg tablets, with an ultimate completion date of September 24, 2025. This non-set-aside competitive award was issued on September 23, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical vendor...
- The Defense Logistics Agency awarded a $19,605.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets in quantities of 30s, with a completion date of September 29, 2025. This is a non-set-aside competitive award issued to the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader federal contract portfolio supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) valued at $6,519.84 under a Firm Fixed Price contract type. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and serves as a critical pharmaceutical distributor for...
- On January 7, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $2,406.24 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by January 8, 2026, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZPFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,100.64 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count unit dose packaging) with a completion date of January 9, 2026. This firm fixed-price, non-competitive delivery order was awarded on January 8, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent capability to fulfill government pharmaceutical procurement requirements, with the company regularly delivering specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 1/7/26 |